Article
Implications of HIV variability for transmission: scientific and policy issues
Registro en:
EXPERT GROUP OF THE JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS. Implications of HIV variability for transmission: scientific and policy issues. AIDS, v. 11, n. 4, p. 1-15, 1997.
0269-9370
Autor
Expert Group of the Joint United Nations Programme on HIV/AIDS
Resumen
Castro Filho, Bernardo Galvão. Fundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Laboratório de Avançado de Saúde Pública. Salvador, BA, Brasil. Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta à informação no documento. Members of the Expert Group of the Joint United Nations Programme on HIV/AIDS (UNAIDS), 27–29 March 1996, Berlin, Germany Roy Anderson (Chairman), University of Oxford, Oxford, UK. Françoise Barré-Sinoussi, Institute Pasteur, Paris, France. James Bradac, Division of AIDS, Vaccine and Prevention Research Programme, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA. Donald S.Burke, Walter Reed Army Institute of Research, Rockville, Maryland, USA. Max Essex, Harvard AIDS Institute, Harvard School of Public Health, Boston, Massachusetts, USA. Eva-Maria Fenyö, Karolinska Institute, MTC, Stockholm, Sweden. Bernardo Galvao-Castro, Ministério da Sáude, Fundaçao Oswaldo Cruz, Laboratorio Avançado de Sáude Publica, Salvador, Brazil. Dale J. Hu (Co-rapporteur), International Activity, Division of HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Harold Jaffe, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Edward Karamov, D.I.Ivanovsky Institute of Virology, Moscow, Russia. Carla Kuiken, Faculty of Medicine, University of Amsterdam, Amsterdam, The Netherlands. Chaiyos Kunanusont, AIDS Division, Department of Communicable Diseases Control, Ministry of Public Health, Bangkok, Thailand.
Marie Laga, STD/HIV Research and Intervention Unit, Department of Microbiology, Institute of Tropical Medicine, Antwerp, Belgium. Johanes Löwer, Paul-Ehrlich-Institut, Federal Office for Sera and Vaccines, Langen, Germany. Timothy Mastro, HIV/AIDS Collaboration, Bangkok, Thailand.
Francine E. McCutchan (Co-rapporteur), the Henry M. Jackson Foundation Research Laboratory, Rockville, Maryland, USA. Alex Opio, National STD/AIDS Control Programme, Ministry of Health, Entebbe, Uganda. Georg Pauli, Robert-Koch-Institut, Federal Institute for Infectious and Non-Communicable Diseases, Berlin, Germany. Donald Sutherland, Laboratory Center for Disease Control, Ottawa, Canada. Bernhard Schwartländer, Robert-Koch Institute, Federal Institute for Infectious and on Communicable Diseases, Berlin, Germany. Isabelle de Vincenzi, European Centre for
Epidemiological Monitoring of HIV/AIDS, SaintMaurice, France. Hagen von Briesen, Chemo-Therapeutisches Forschungsinstitut Georg-Speyer-Haus, Frankfurt am Main, Germany. Chantapong Wasi, Faculty of Medicine Siriraj
Hospital, Mahidol University, Bangkok, Thailand. Jonathan Weber, GU Medicine and Communicable Diseases, St Mary’s Hospital Medical School, London, UK. Peter Piot (Co-chairman), Michel Caraël, Saladin Osmanov (Co-rapporteur), Joint United Nations Programme on HIV/AIDS, Geneva, Switzerland.